⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

LEGN

Legend Biotech Corporation

Healthcare · Biotechnology

19.91USD

-0.5800 (-2.83%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End03/2026 Q1
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 19.91
P/E—
Dvd Ind Yld—
P/B4.12
P/S3.5
Curr EV/T12M EBITDA-83.7
Mkt Cap (USD)4.0B
Curr EV (USD)3.5B
2)

Per Share Data

EPS T12M-1.36
DPS—
Bk Val Per Sh6.35
Rev/Sh6.15
Cash/Sh4.98
Curr Shares Out194.5M
FCF/Sh-0.63
3)

Cash Flow Analysis

P/CF-48.8
Curr P/FCF-34.4
CF/NI0.3
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-7.2%
Eff Interest Rate7.6%
4)

Growth Potential

Dil EPS 1Y Gr-68.8%
Cap 1Y Gr-1.5%
BPS 1Y Gr-4.5%
R&D To Sales35.0%
Retention Rate100.0%
Rev 1Y Gr64.0%
FCF 1Y Gr18.5%
Assets 1Y Gr3.8%
5)

Profitability

EBITDA-0.1B
EBIT-0.1B
Operating Margin-11.9%
Pretax Margin-20.8%
Net Margin-22.0%
ROA-15.6%
ROE-25.2%
ROC—
Asset Turnover0.71
6)

Structure

Current Ratio2.13
Quick Ratio2.88
Debt/Assets27.4%
Debt/Com Eq45.3%
Net Debt/EBITDA2.16
Tot Debt/Capital31.2%
Gross Margin55.0%
EBIT/Int Exp-6.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.